Bockrath R C, Osborn M, Person S
J Bacteriol. 1968 Jul;96(1):146-53. doi: 10.1128/jb.96.1.146-153.1968.
Previously, arginine revertants of Escherichia coli WWU, a derivative of E. coli 15T(-), have been subdivided by two independent methods: (i) the streak morphology on nutrient agar, and (ii) the pattern of phage growth using amber and ochre mutants of bacteriophage T4. In the first assay, revertants were subdivided into two classes according to the appearance of streaks after incubation on nutrient agar, a thick, even line of growth defining normal revertants and a thin, irregular line defining aberrant revertants. In the second assay, revertants were classified by the suppressors they contained. The present work demonstrates that revertants containing an amber suppressor show the aberrant morphology and are also able to catabolize thymidine for energy and carbon. This is in contrast to the parent WWU containing no suppressor, which shows a normal morphology and cannot utilize thymidine as an energy source. Revertants containing no suppressor, isolated specifically for their ability to catabolize thymidine, show an aberrant morphology. Together, these results indicate that the aberrant morphology results from suppression of an amber triplet in a gene of the thymidine catabolic pathway. Enzyme assays show the amber triplet to be in the gene specifying deoxyribomutase. It is suggested that the aberrant arginine revertants are analogous to high thymine-requiring mutants and that, in general, high and low thymine-requiring mutants differ from one another in their ability to catabolize deoxyribose-1-phosphate.
此前,大肠杆菌WWU(大肠杆菌15T(-)的衍生物)的精氨酸回复突变体已通过两种独立方法进行细分:(i)在营养琼脂上的划线形态,以及(ii)使用噬菌体T4的琥珀突变体和赭石突变体的噬菌体生长模式。在第一种测定中,根据在营养琼脂上孵育后划线的外观,将回复突变体细分为两类,粗壮、均匀的生长线定义为正常回复突变体,细而不规则的线定义为异常回复突变体。在第二种测定中,根据回复突变体所含的抑制子对其进行分类。目前的研究表明,含有琥珀抑制子的回复突变体表现出异常形态,并且还能够分解胸苷以获取能量和碳源。这与不含抑制子的亲本WWU形成对比,亲本WWU表现出正常形态,且不能利用胸苷作为能量来源。专门因其分解胸苷的能力而分离出的不含抑制子的回复突变体表现出异常形态。总之,这些结果表明异常形态是由胸苷分解代谢途径基因中的琥珀三联体抑制所致。酶活性测定表明琥珀三联体存在于指定脱氧核糖突变酶的基因中。有人提出,异常的精氨酸回复突变体类似于高胸腺嘧啶需求突变体,并且一般来说,高胸腺嘧啶需求突变体和低胸腺嘧啶需求突变体在分解代谢脱氧核糖-1-磷酸的能力上彼此不同。